Nicotinamide riboside: A promising therapy for MI-induced acute kidney injury by upregulating nicotinamide phosphoribosyltransferase-mediated NAD levels
Nada J. Habeichi, Ghadir Amin, Solène Emmanuelle Boitard, Cynthia Tannous, Rana Ghali, Iman Momken, Reine Diab, George W. Booz, Mathias Mericskay, Fouad Anthony Zouein
This study shows that nicotinamide riboside (NR) improves kidney function and reduces damage in mice after myocardial infarction by increasing NAD levels via NAMPT.
Journal of the American Heart Association · Feb 26, 2025Peer-reviewedPharmacology & Toxicology